Stock 002020 ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Jingxin Pharmaceutical Co., Ltd.

Equities

002020

CNE000001K73

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
11.24 CNY +8.91% Intraday chart for Zhejiang Jingxin Pharmaceutical Co., Ltd. +9.34% -11.64%
Apr. 23 Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. is a China-based company engaged in manufacture of pharmaceuticals. The Company's pharmaceutical products include chemical pharmaceuticals, traditional medicines, biological agents and bulk pharmaceutical chemicals. Its pharmaceutical products are mainly applied in cardiovascular sector, digestive tract sector and psychoneural sector, among others. The Company is also engaged in the research and development, manufacture and sales of medical devices. Its medical devices include clinical displays, diagnosis displays, endoscopic surgery displays and ultrasonic image displays, among others. The Company operates its businesses in both domestic and overseas markets.

Number of employees: 3,909

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Manufacturing
83.9 %
3,141 83.1 % 3,354 83.9 % +6.78%
Medical Instrument
16.1 %
638 16.9 % 645 16.1 % +0.96%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
82.6 %
3,064 81.1 % 3,304 82.6 % +7.81%
Foreign
17.4 %
715 18.9 % 695 17.4 % -2.86%

Managers

Managers TitleAgeSince
Tian Qing Hu CHM
 Chairman 60 -
Mei Li Chen DFI
 Director of Finance/CFO 54 -
Gang Lü CHM
 Chairman 62 -
Yun Fei Hong COO
 Chief Operating Officer 44 -
Fen Juan Lin BRD
 Director/Board Member 44 02-06-30
Zhi Ping Jin BRD
 Director/Board Member 43 -
Neng Neng Wang BRD
 Director/Board Member 51 -
Bo Zhang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Gang Lü CHM
 Chairman 62 -
Neng Neng Wang BRD
 Director/Board Member 51 -
Da Liang Zhang BRD
 Director/Board Member 61 22-10-12
Mei Li Chen DFI
 Director of Finance/CFO 54 -
Zhi Ping Jin BRD
 Director/Board Member 43 -
Yun Fei Hong COO
 Chief Operating Officer 44 -
Wan Hu BRD
 Director/Board Member - 22-06-26
Pan Xu BRD
 Director/Board Member 37 22-10-12
Xiao Jun Xu BRD
 Director/Board Member 51 -
Ying Lei BRD
 Director/Board Member 67 22-10-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 861,029,140 496,891,764 ( 57.71 %) 0 57.71 %

Shareholders

NameEquities%Valuation
Gang Lü
17.08 %
112,098,015 17.08 % 166 M ¥
Yue Ying Lu
3.568 %
23,419,200 3.568 % 35 M ¥
Perseverance Asset Management LP
2.328 %
15,282,700 2.328 % 23 M ¥
Shanghai State-Owned Assets Supervision & Administration
1.875 %
12,309,900 1.875 % 18 M ¥
Bank of China Investment Management Co., Ltd.
1.707 %
11,203,917 1.707 % 17 M ¥
Citic Securities Co., Ltd. (Invt Port)
1.662 %
10,910,300 1.662 % 16 M ¥
Min Yu
1.177 %
7,725,600 1.177 % 11 M ¥
Geng Sheng Yu
1.068 %
7,007,500 1.068 % 10 M ¥
Fang Ying Tang
0.9953 %
6,533,100 0.9953 % 10 M ¥
Xiao Wei
0.9750 %
6,400,000 0.9750 % 10 M ¥
NameEquities%Valuation
Gang Lü
98.55 %
201,665,133 98.55 % 299 M ¥

Company contact information

Zhejiang Jingxin Pharmaceutical Co., Ltd.

No. 800 East Road Xinchang Avenue

312500, Shaoxing

+

http://www.jingxinpharm.com
address Zhejiang Jingxin Pharmaceutical Co., Ltd.(002020)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.24
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. Stock Zhejiang Jingxin Pharmaceutical Co., Ltd.
-11.64% 1.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 660B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.87% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.09% 219B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 196B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002020 Stock
  4. Company Zhejiang Jingxin Pharmaceutical Co., Ltd.